| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
1.132 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
1.132 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
1.132 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
STAT3 |
|
1.132 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.132 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
1.132 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
RIN1 |
RIN1: Ras and Rab interactor 1 |
1.132 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
1.132 |
Evidence |
|
| PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
| PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
1.132 |
Evidence |
|
| GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|
| GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
1.132 |
Evidence |
|
| ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.132 |
Evidence |
|
| ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
1.132 |
Evidence |
|
| ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.132 |
Evidence |
|
| ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
1.132 |
Evidence |
|
| ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
HES6 |
HES6: Transcription cofactor HES-6 |
1.132 |
Evidence |
|
| TFAP4 |
TFAP4: Transcription factor AP-4 |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
1.132 |
Evidence |
|
| TFAP4 |
TFAP4: Transcription factor AP-4 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
1.132 |
Evidence |
|
| TFAP4 |
TFAP4: Transcription factor AP-4 |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.132 |
Evidence |
|
| TFAP4 |
TFAP4: Transcription factor AP-4 |
HES6 |
HES6: Transcription cofactor HES-6 |
1.132 |
Evidence |
|
| TFAP4 |
TFAP4: Transcription factor AP-4 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
1.132 |
Evidence |
|
| TFAP4 |
TFAP4: Transcription factor AP-4 |
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
1.132 |
Evidence |
|